0001127602-21-013489.txt : 20210408
0001127602-21-013489.hdr.sgml : 20210408
20210408172606
ACCESSION NUMBER: 0001127602-21-013489
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210407
FILED AS OF DATE: 20210408
DATE AS OF CHANGE: 20210408
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DWEK RAYMOND
CENTRAL INDEX KEY: 0001231617
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26301
FILM NUMBER: 21815757
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp
CENTRAL INDEX KEY: 0001082554
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 521984749
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
BUSINESS PHONE: 3016089292
MAIL ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
FORMER COMPANY:
FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP
DATE OF NAME CHANGE: 19990324
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2021-04-07
0001082554
UNITED THERAPEUTICS Corp
UTHR
0001231617
DWEK RAYMOND
C/O UNITED THERAPEUTICS CORPORATION
1040 SPRING STREET
SILVER SPRING
MD
20910
1
Common Stock
2021-04-07
4
M
0
2000
54.77
A
2000
D
Common Stock
2021-04-07
4
D
0
2000
191.10
D
0
D
Share Tracking Award
54.77
2021-04-07
4
M
0
2000
0
D
2012-06-29
2021-06-29
Common Stock
2000
8000
D
This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. These awards were granted June 29, 2011 and were set to expire June 29, 2021.
/s/ John S. Hess, Jr. under Power of Attorney
2021-04-08